AU1884297A - Recombinant protein containing a c-terminal fragment of plasmodium msp-1 - Google Patents

Recombinant protein containing a c-terminal fragment of plasmodium msp-1

Info

Publication number
AU1884297A
AU1884297A AU18842/97A AU1884297A AU1884297A AU 1884297 A AU1884297 A AU 1884297A AU 18842/97 A AU18842/97 A AU 18842/97A AU 1884297 A AU1884297 A AU 1884297A AU 1884297 A AU1884297 A AU 1884297A
Authority
AU
Australia
Prior art keywords
recombinant protein
protein containing
terminal fragment
plasmodium msp
msp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18842/97A
Inventor
John W. Barnwell
Shirley Longacre-Andre
Kamini Mendis
Faridabano Nato
Charles Roth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
New York University NYU
Original Assignee
Institut Pasteur de Lille
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille, New York University NYU filed Critical Institut Pasteur de Lille
Publication of AU1884297A publication Critical patent/AU1884297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU18842/97A 1996-02-14 1997-02-14 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 Abandoned AU1884297A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9601821A FR2744723A1 (en) 1996-02-14 1996-02-14 RECOMBINANT PROTEIN CONTAINING A C-TERMINAL FRAGMENT OF AN MSP-1 PROTEIN FROM A PLASMODIUM INFECTIOUS TO MAN FOR THE PRODUCTION OF ANTI-MALARIA VACCINES
FR9601821 1996-02-14
PCT/FR1997/000291 WO1997030159A2 (en) 1996-02-14 1997-02-14 Recombinant protein containing a c-terminal fragment of plasmodium msp-1

Publications (1)

Publication Number Publication Date
AU1884297A true AU1884297A (en) 1997-09-02

Family

ID=9489187

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18842/97A Abandoned AU1884297A (en) 1996-02-14 1997-02-14 Recombinant protein containing a c-terminal fragment of plasmodium msp-1

Country Status (7)

Country Link
EP (1) EP0880589A2 (en)
JP (1) JP2000506381A (en)
KR (1) KR20000065265A (en)
AU (1) AU1884297A (en)
CA (1) CA2245727A1 (en)
FR (1) FR2744723A1 (en)
WO (1) WO1997030159A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0885012A4 (en) 1996-01-29 2001-09-05 Univ Georgetown Malaria vaccine based upon the addition of a msa1 peptide
GB9616351D0 (en) * 1996-08-02 1996-09-11 Smithkline Beecham Biolog Vaccine composition
WO1999020766A2 (en) 1997-10-20 1999-04-29 Genzyme Transgenics Corporation NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
US20030100106A1 (en) * 2000-02-08 2003-05-29 Chang Sandra P. Baculovirus produced Plasmodium falciparum vaccine
KR100373918B1 (en) * 2000-02-17 2003-02-26 주식회사 엘지생명과학 Enzyme immuno assay for malaria and reagent used therefor
AU2002248392A1 (en) 2001-01-26 2002-08-06 Walter Reed Army Institute Of Research Recombinant plasmodium falciparum merozoite protein-1/42 vaccine
US7595191B2 (en) 2001-01-26 2009-09-29 The United States Of America As Represented By The Secretary Of The Army Isolation and purification of P. falciparum merozoite protein-142 vaccine
US7306806B2 (en) 2001-01-26 2007-12-11 United States Of America As Represented By The Secretary Of The Army Recombinant P. falciparum merozoite protein-142 vaccine
EP1370581A2 (en) * 2001-03-19 2003-12-17 Walter Reed Army Institute of Research Recombinant p. vivax merozoite protein-1 p42 vaccine
CA2480786A1 (en) 2002-04-01 2003-10-16 Evelina Angov Recombinant p. falciparum merozoite protein-142 vaccine
WO2015055772A1 (en) 2013-10-16 2015-04-23 Shirley Longacre Combination of plasmodium merozoite surface proteins msp4 and 1 and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK79985A (en) * 1984-02-22 1985-08-23 Wellcome Found Cloning DNA for PROTOCOL ANTIGENES AND ITS USE

Also Published As

Publication number Publication date
CA2245727A1 (en) 1997-08-21
EP0880589A2 (en) 1998-12-02
FR2744723A1 (en) 1997-08-14
WO1997030159A3 (en) 1997-12-31
JP2000506381A (en) 2000-05-30
KR20000065265A (en) 2000-11-06
WO1997030159A2 (en) 1997-08-21

Similar Documents

Publication Publication Date Title
HU9601120D0 (en) Recombinant obese proteins
AU6198298A (en) Preparation of recombinant FVIII in a protein free medium
PL336889A1 (en) Preparations of activated protein c
AU6255096A (en) Pegylated modified proteins
IL132537A0 (en) Truncated vegf-related proteins
PL325113A1 (en) Novell opiodic peptides
AU5283793A (en) Recombinant specific binding protein
AUPO758297A0 (en) Control of acidic gut syndrome
EP0785276A4 (en) Modification of peptide and protein
GB9718609D0 (en) Fusion protein
AU1884297A (en) Recombinant protein containing a c-terminal fragment of plasmodium msp-1
AU1655297A (en) Anti-Fas recombinant antibodies and DNA therefor
AU5635896A (en) Recombinant endotoxin-neutralizing proteins
IL116973A0 (en) Extraction of recombinant proteins
AU5021796A (en) Recombinant human anti-lewis b antibodies
GB9714680D0 (en) Recombinant production of proteins
AU1535899A (en) Genes encoding frizzled-like proteins
EP1029034A4 (en) Signal peptide containing proteins and uses therefor
AU6275098A (en) Novel h-rev 107-like protein
AU4661697A (en) Pfs28 fusion proteins
GB9714681D0 (en) Recombinant production of proteins
AU9318798A (en) Ras-like protein
AU1805200A (en) Method of separating basic peptide or basic protein
AUPP086497A0 (en) Method of producing recombinant protein
GB9607072D0 (en) Polypeptides derived from wasp protein